We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+25.67%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
+$8.92B
Cap. Flow
+$6.38B
Cap. Flow %
38.87%
Top 10 Hldgs %
11.97%
Holding
501
New
64
Increased
117
Reduced
241
Closed
32

Top Buys

Rank Stock Value
1
PINS icon
Pinterest
PINS
+$181M
2
CRWD icon
CrowdStrike
CRWD
+$173M
3
RNG icon
RingCentral
RNG
+$166M
4
SNPS icon
Synopsys
SNPS
+$158M
5
WCN
Waste Connections
WCN
+$152M

Sector Composition

Rank Sector Weight
1 Technology 28.21%
2 Healthcare 20.91%
3 Industrials 14.05%
4 Consumer Discretionary 13.18%
5 Financials 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APD icon
351
Air Products & Chemicals
APD
$67.1B
$7.64M 0.05%
27,951
-46,790
-63% -$13.2M
PRLB icon
352
Protolabs
PRLB
$1.95B
$7.62M 0.05%
49,659
-1,400
-3% -$197K
HAIN icon
353
Hain Celestial
HAIN
$67.5M
$7.5M 0.05%
+186,904
New +$6.8M
LMT icon
354
Lockheed Martin
LMT
$121B
$7.44M 0.05%
20,958
-18,728
-47% -$6.88M
WRB icon
355
W.R. Berkley
WRB
$25.7B
$7.43M 0.05%
251,843
-12,476
-5% -$360K
RYAAY icon
356
Ryanair
RYAAY
$28.7B
$7.3M 0.04%
165,940
-13,695
-8% -$537K
BAP icon
357
Credicorp
BAP
$30.4B
$7.21M 0.04%
43,965
-3,628
-8% -$503K
TER icon
358
Teradyne
TER
$55.8B
$7.19M 0.04%
60,000
-2,200
-4% -$225K
CDNS icon
359
Cadence Design Systems
CDNS
$80.6B
$7.18M 0.04%
+52,616
New +$6.17M
PFE icon
360
Pfizer
PFE
$162B
$7.17M 0.04%
194,695
-307,276
-61% -$11.3M
NVS icon
361
Novartis
NVS
$304B
$7.17M 0.04%
75,878
-6,261
-8% -$547K
NXPI icon
362
NXP Semiconductors
NXPI
$57.5B
$7.08M 0.04%
44,525
BEAT
363
DELISTED
BioTelemetry, Inc.
BEAT
$7.04M 0.04%
97,737
-4,700
-5% -$246K
CME icon
364
CME Group
CME
$101B
$7.03M 0.04%
38,612
BHP icon
365
BHP
BHP
$230B
$6.98M 0.04%
119,708
-9,877
-8% -$495K
CSL icon
366
Carlisle Companies
CSL
$14B
$6.95M 0.04%
44,509
+22,241
+100% +$3.12M
ADI icon
367
Analog Devices
ADI
$176B
$6.89M 0.04%
46,676
-28,899
-38% -$3.83M
NVO
368
Novo Nordisk
NVO
$206B
$6.87M 0.04%
196,772
-16,236
-8% -$561K
TWTR
369
DELISTED
Twitter, Inc.
TWTR
$6.83M 0.04%
126,121
+4,946
+4% +$236K
BRKR icon
370
Bruker
BRKR
$8.91B
$6.78M 0.04%
125,332
-6,100
-5% -$292K
ENB icon
371
Enbridge
ENB
$109B
$6.71M 0.04%
209,919
-17,321
-8% -$527K
VCEL icon
372
Vericel Corp
VCEL
$2.06B
$6.71M 0.04%
217,300
-1,700
-0.8% -$40.5K
CNS icon
373
Cohen & Steers
CNS
$4.11B
$6.7M 0.04%
90,101
-4,200
-4% -$277K
SMTC icon
374
Semtech
SMTC
$13.8B
$6.7M 0.04%
92,870
-4,400
-5% -$281K
EEFT icon
375
Euronet Worldwide
EEFT
$2.76B
$6.62M 0.04%
45,685
-31,190
-41% -$3.63M

Similar funds

Carillon Tower Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Carillon Tower Advisers held 501 positions worth $16.4B, up 119% from $7.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Carillon Tower Advisers deployed $6.38B of net new capital in Q4 2020, opening 64 new positions and adding to 117 existing holdings. Its largest new stake was Pinterest: 3,021,131 shares worth $199M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Q2 Holdings, an estimated $278M trimmed.

  • Carillon Tower Advisers's largest Q4 2020 buy was Pinterest: 3,021,131 shares worth $199M.
  • Carillon Tower Advisers added most to CrowdStrike in Q4 2020, an estimated $173M increase.
  • Carillon Tower Advisers's biggest Q4 2020 reduction was Q2 Holdings, cutting an estimated $278M.
  • Carillon Tower Advisers fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2020, selling an estimated $31.6M.
  • Carillon Tower Advisers's ten largest holdings make up 12% of its $16.4B portfolio in Q4 2020.
  • Carillon Tower Advisers opened 64 new positions and closed 32 in Q4 2020.
  • Carillon Tower Advisers's portfolio value rose 119% quarter-over-quarter to $16.4B.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.